Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 523 Records) |
| Query Trace: Adenocarcinoma and TP53[original query] |
|---|
| Prediction of EGFR-TP53 genes co-mutations in patients with lung adenocarcinoma (LUAD) by F-FDG PET/CT radiomics. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 9 . Shuheng Li, Yujing Hu, Congna Tian, Jiusong Luan, Xinchao Zhang, Qiang Wei, Xiaodong Li, Yanzhu Bi |
| Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy. Journal of cancer research and clinical oncology 2024 9 150 (9): 413. Guomin Gu, Chunling Liu, Xiaodan Zhu, Yan Yang, Shuming Song, Yan Zhao, Gang S |
| Next-generation sequencing as a valuable tool for mutational spectrum in advanced-stage NSCLC patients. Medicine and pharmacy reports 2024 9 97 (3): 298-307. Ioana Iurca, Ecaterina Isakescu, Laura Ancuta Pop, Liviuta Budisan, Radu Pirlog, Antonia Harangus, Tudor Eliade Ciuleanu, Cornelia Braicu, Ioana Berindan-Neag |
| Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA (ctDNA) in Routine Clinical Practice. Oncology 2024 9 1-24. Shaheenah Dawood, Nippun Sandhir, Marwan Akasheh, Maroun El Khoury, Sonia Otsmane, Muath Alnassar, Omalkhair Abulkhair, Fadi Farhat, Steve Ols |
| Dissecting the clinicopathological, genomic, and prognostic significance of ALK rearrangement in resected lung adenocarcinoma. The Journal of thoracic and cardiovascular surgery 2024 9 . Hang Cao, Wangyang Zhu, Huatao Tang, Chaoqiang Deng, Fangqiu Fu, Yuan Li, Yang Zhang, Haiquan Ch |
| Immunohistochemistry of p53 surrogates TP53 mutation as an accurate predictor for early-relapse of surgically resected stage I-III lung adenocarcinoma. JTCVS open 2024 9 20 183-193. Yasuyuki Kurihara, Takayuki Honda, Akira Takemoto, Katsutoshi Seto, Satoshi Endo, Kousuke Tanimoto, Susumu Kirimura, Masashi Kobayashi, Shunichi Baba, Yasuhiro Nakashima, Ryo Wakejima, Rie Sakakibara, Hironori Ishibashi, Johji Inazawa, Toshihiro Tanaka, Yasunari Miyazaki, Kenichi Oku |
| The NF1 gene mutations and co-mutations in lung adenocarcinomas with brain metastasis. Indian journal of pathology & microbiology 2024 9 . Nesibe Kahraman-Cetin, Dilara Akin, Seda Orenay-Boyacioglu, Olcay Boyacioglu, Ibrahim Halil Erdogdu, Esin Oktay, Ibrahim Meteog |
| Evaluation of the novel International Association for the Study of Lung Cancer grading system in adenocarcinoma with spread through air space. Translational lung cancer research 2024 9 13 (8): 1862-1876. Kuan Xu, Yilv Lv, Tangbing Chen, Yuchen Han, Hanqing Huang, Hong Yu, Bo |
| Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 8 JCO2400186. Paul Johannet, Somer Abdelfattah, Callahan Wilde, Shrey Patel, Henry Walch, Benoit Rousseau, Guillem Argiles, Oliver Artz, Miteshkumar Patel, Andrea Arfe, Andrea Cercek, Rona Yaeger, Karuna Ganesh, Nikolaus Schultz, Luis A Diaz, Michael B Foo |
| Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology-proven malignant pleural effusions. Cancer cytopathology 2024 8 . Cristiana M Pineda, Adnan Majid, Daniel B Costa, Paul A VanderLa |
| TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations. Frontiers in oncology 2024 8 14 1357583. Armin Frille, Myriam Boeschen, Hubert Wirtz, Mathias Stiller, Hendrik Bläker, Maximilian von Laffe |
| [Gene mutation characteristics of clinical stage ?A lung adenocarcinoma and their relations with patients' long-term prognosis]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2024 8 46 (8): 755-763. L Zhang, M W Liu, L Li, S Zhao, L L Wu, Z H Yin, M Li, Y N Gao, N |
| Comprehensive Analysis Reveals Epithelial Growth Factor Receptor as a Potential Diagnostic Biomarker in Glioblastoma Multiforme. Cureus 2024 8 16 (7): e64506. Amna Makawi, Somia A Khalafallah, Israa M Faris, Mohamed Alfa |
| Holliday junction recognition protein (HJURP) could reflect the clinical outcomes of lung adenocarcinoma patients, and impact the choice of precision therapy. Frontiers in genetics 2024 12 15 1475511. Xixi Gao, Yingqing Zhang, Ming Zhang, Yuejiao S |
| IDENTIFICATION OF CLINICALLY RELEVANT GENE VARIANTS IN COLON ADENOCARCINOMA SAMPLES OF UKRAINIAN PATIENTS USING A COMPREHENSIVE CANCER PANEL: A PILOT STUDY. Experimental oncology 2024 12 46 (3): 221-227. G Gerashchenko, R Gulkovskyi, N Melnichuk, N Hryshchenko, T Marchyshak, O Mankovska, A Bezverkhiy, I Kotuza, L Rosha, A Kotuza, Z Tkachuk, V Kashuba, M Tuka |
| Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in Non-Small Cell Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 12 . Daniele Tavernari, Maxime Borgeaud, Ximeng Liu, Parikh Kaushal, Xiuning Le, Giovanni Ciriello, Alfredo Add |
| PIK3CA Mutations and Co-Mutations in Operated Non-Small Cell Lung Carcinoma. Journal of clinical medicine 2024 12 13 (23): . Salih Cokpinar, Ibrahim Halil Erdogdu, Seda Orenay-Boyacioglu, Olcay Boyacioglu, Nesibe Kahraman-Cetin, Ibrahim Meteog |
| The Landscape of Circulating Tumor DNA (ctDNA) in Appendiceal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 12 . Michael G White, Mohammad A Zeineddine, Eleanor A Fallon, Fadl A Zeineddine, Julia Dansby, Saikat Chowdhury, Nicholas Hornstein, Abdelrahman Yousef, Mahmoud Yousef, Neal Bhutiani, Yue Gu, Bryan Kee, Arvind Dasari, Michael J Overman, Kanwal Raghav, Scott Kopetz, Abhineet Uppal, Melissa Taggart, Timothy Newhook, Keith Fournier, Beth Helmink, Leylah M Drusbosky, John Paul Sh |
| Genetic profile in primary tumor tissue of advanced lung adenocarcinoma patients with adrenal metastasis. Cancer genetics 2024 12 290-291 36-43. Haiqiao Pan, Hongbin Zhang, Yongqian Zhang, Xiaojing Chen, Zhai Liu, Yajing Wu, Na Bai, Yan Shi, Min Zhao, Lingling Z |
| Putative mechanisms of primary resistance to EGFR-targeted therapies: A retrospective study. Lung cancer (Amsterdam, Netherlands) 2024 11 197 107998. Xueliang Tu, Zhongyu Lu, Fengrong Hei, Tong Zhang, Xiaoxuan Wang, Dongsheng Chen, Fengjuan Fan, Jing Xu, Xing Zhang, Kefeng G |
| Identification of Molecular Subtypes and Prognostic Traits Based on Chromosomal Instability Phenotype-Related Genes in Lung Adenocarcinoma. Cancers 2024 11 16 (22): . Youngsic Jeon, Kyung-Chul Choi, Young Nyun Park, Young-Joo K |
| Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study. Cancers 2024 11 16 (22): . Joan Llach, Irina Luzko, Julie Earl, Emma Barreto, Mercedes Rodríguez-Garrote, Marc Lleixà, Cristina Herrera-Pariente, Guerau Fernández, Jenifer Munoz, Laia Bonjoch, Tamara Saurí, Fabio Ausania, Teresa Ocaña, Lorena Moreno, Elia Grau, Josep Oriola, Maria Isabel Alvarez-Mora, Marta Herreros-Villanueva, Sergi Castellví-Bel, Francesc Balaguer, Luis Bujanda, Leticia Morei |
| Genomic Landscape Features of Minimally Invasive Adenocarcinoma and Invasive Lung Adenocarcinoma. Global medical genetics 2024 11 11 (4): 312-318. Wei Zhang, Hui Xu, Ning Tang, Shuang Han, Hongyan S |
| Pooled Analysis of the Prognostic Significance of Epidermal Growth Factor Receptor (EGFR) Mutational Status in Combination with Other Driver Genomic Alterations in Stage I Resected Invasive Lung Adenocarcinoma for Recurrence-Free Survival: A Population-Based Study. Annals of surgical oncology 2024 11 . Yufei Huang, Hui Zeng, Guochao Zhang, Fangzhou Ren, Zhenlong Yuan, Jingyu Ren, Jiaxi Xu, Zehao Song, Wenbin Li, Jianming Ying, Feiyue Feng, Fengwei T |
| Mutational Landscape of Gastric Adenocarcinoma of the Fundic Gland Type Revealed by Whole Genome Sequencing. Cancer medicine 2024 10 13 (19): e70290. Hu Wei, Ze Min Chen, Xiu Fen Xue, Li Xia Xi, Gen Hua Yang, Zhi Yong Zhai, Zhao Yu Huang, Ping Zhou, Chong Ju Bao, Li Juan You, Mei Ping Ou Yang, Gui Li Xia, Zhi Yu Zeng, Xiao Bing Cui, Xiao Juan Pei, Wei Go |
| Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study. EBioMedicine 2024 10 109 105373. Rémy Nicolle, Cindy Canivet, Laurent Palazzo, Bertrand Napoléon, Mira Ayadi, Camille Pignolet, Jérôme Cros, Sophie Gourgou, Janick Selves, Jérôme Torrisani, Nelson Dusetti, Pierre Cordelier, Louis Buscail, Barbara Bournet, |
| Prognostic value of the TP53 mutation in patients with pancreatic ductal adenocarcinoma receiving FOLFIRINOX. Therapeutic advances in medical oncology 2024 10 16 17588359241290482. Min Kyu Kim, In Rae Cho, Yooeun Kim, Jin Ho Choi, Kwangrok Jung, Jaihwan Kim, Sheehyun Kim, Hongseok Yun, Jeesun Yoon, Do-Youn Oh, Kwangsoo Kim, Sang Hyub L |
| Molecular Profiling of Low-Grade Appendiceal Mucinous Neoplasms (LAMN). Genes, chromosomes & cancer 2024 10 63 (10): e23270. Julia Doll, Katja Maurus, Franziska Köhler, Niels Matthes, Johan F Lock, Christoph-Thomas Germer, Andreas Rosenwald, Armin Wiegeri |
| Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer. Exploration of targeted anti-tumor therapy 2025 1 5 (6): 1435-1449. Hortense De Saint Basile, Reza Elaidi, Zineb Maaradji, Hélène Blons, Rym BenDhiab, Laure Gibault, Elizabeth Fab |
| Comprehensive analysis of genomic alterations and novel prognostic biomarkers, and establishment of prediction models of metastasis in metastatic non-small cell lung cancer. Journal of Cancer 2025 1 16 (1): 339-350. Kangwei Wang, Meifeng Ye, Zexun Mo, Xiaomei Huang, Yujun Li, Shuquan W |
- Page last reviewed:Feb 1, 2024
- Content source: